1. Home
  2. ZVRA vs NAVI Comparison

ZVRA vs NAVI Comparison

Compare ZVRA & NAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$9.81

Market Cap

689.4M

Sector

Health Care

ML Signal

HOLD

Logo Navient Corporation

NAVI

Navient Corporation

HOLD

Current Price

$8.47

Market Cap

760.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVRA
NAVI
Founded
2006
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
689.4M
760.4M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
ZVRA
NAVI
Price
$9.81
$8.47
Analyst Decision
Strong Buy
Hold
Analyst Count
9
7
Target Price
★ $25.00
$9.00
AVG Volume (30 Days)
744.9K
★ 1.1M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
★ 7.22%
EPS Growth
★ 159.21
N/A
EPS
★ 0.74
0.44
Revenue
$106,470,000.00
★ $271,000,000.00
Revenue This Year
$43.97
$56.36
Revenue Next Year
$15.93
$6.64
P/E Ratio
★ $14.00
$20.13
Revenue Growth
★ 350.91
N/A
52 Week Low
$8.01
$7.33
52 Week High
$15.04
$13.48

Technical Indicators

Market Signals
Indicator
ZVRA
NAVI
Relative Strength Index (RSI) 36.35 36.98
Support Level $9.29 $7.91
Resistance Level $11.19 $8.73
Average True Range (ATR) 0.46 0.34
MACD -0.03 -0.06
Stochastic Oscillator 3.61 12.23

Price Performance

Historical Comparison
ZVRA
NAVI

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

About NAVI Navient Corporation

Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in two segments: Federal Education Loans, and Consumer Lending. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.

Share on Social Networks: